{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:48:01Z","timestamp":1783540081499,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04468-5","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:31:58Z","timestamp":1783535518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Revealing the dynamics of follicular T cells and checkpoint engagement in surgically resected colorectal cancer and their relations to clinicopathological aspects"],"prefix":"10.1007","author":[{"given":"Asmaa M.","family":"Zahran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5431-6583","authenticated-orcid":false,"given":"Nahla M.","family":"Elsherbiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alshimaa G.","family":"Abdelhakeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Rayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab Gaber","family":"Mahran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Khalid Ibrahim","family":"Elsayh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Refaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwan","family":"Abdelsabour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa A.","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wageeh A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab Albadry M.","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Elashmawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa Gafar","family":"Mansor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"5","key":"4468_CR1","volume":"28","author":"ML T\u00f8rring","year":"2019","unstructured":"T\u00f8rring ML, Falborg AZ, Jensen H, Neal RD, Weller D, Reguilon I, et al. Advanced-stage cancer and time to diagnosis: an International Cancer Benchmarking Partnership (ICBP) cross-sectional study. Eur J Cancer Care (Engl). 2019;28(5):e13100.","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"4","key":"4468_CR2","first-page":"372","volume":"72","author":"F Ciardiello","year":"2022","unstructured":"Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin. 2022;72(4):372\u2013401.","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"4468_CR3","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921\u20135.","journal-title":"Curr Biol"},{"issue":"31","key":"4468_CR4","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1200\/JCO.19.03205","volume":"38","author":"B Mlecnik","year":"2020","unstructured":"Mlecnik B, Bifulco C, Bindea G, Marliot F, Lugli A, Lee JJ, et al. Multicenter international society for immunotherapy of cancer study of the consensus immunoscore for the prediction of survival and response to chemotherapy in stage III colon cancer. J Clin Oncol. 2020;38(31):3638\u201351.","journal-title":"J Clin Oncol"},{"key":"4468_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411673","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Wieder T, Mauerer B, Sch\u00e4fer L, Kesselring R, Braum\u00fcller H. T cells in colorectal cancer: unravelling the function of different T cell subsets in the tumor microenvironment. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241411673.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4468_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.trecan.2022.12.007","volume":"9","author":"N Guti\u00e9rrez-Melo","year":"2023","unstructured":"Guti\u00e9rrez-Melo N, Baumjohann D. T follicular helper cells in cancer. Trends Cancer. 2023;9(4):309\u201325.","journal-title":"Trends Cancer"},{"issue":"8","key":"4468_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.it.2021.06.003","volume":"42","author":"SC Eisenbarth","year":"2021","unstructured":"Eisenbarth SC, Baumjohann D, Craft J, Fazilleau N, Ma CS, Tangye SG, et al. CD4(+) T cells that help B cells - a proposal for uniform nomenclature. Trends Immunol. 2021;42(8):658\u201369.","journal-title":"Trends Immunol"},{"issue":"5","key":"4468_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100262","volume":"2","author":"RS Herati","year":"2021","unstructured":"Herati RS, Silva LV, Vella LA, Muselman A, Alanio C, Bengsch B, et al. Vaccine-induced ICOS(+)CD38(+) circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways. Cell Rep Med. 2021;2(5):100262.","journal-title":"Cell Rep Med"},{"key":"4468_CR9","doi-asserted-by":"publisher","first-page":"1036616","DOI":"10.3389\/fimmu.2022.1036616","volume":"13","author":"Y Lv","year":"2022","unstructured":"Lv Y, Ricard L, Gaugler B, Huang H, Ye Y. Biology and clinical relevance of follicular cytotoxic T cells. Front Immunol. 2022;13:1036616.","journal-title":"Front Immunol"},{"key":"4468_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.724139","volume":"13","author":"Q Zou","year":"2022","unstructured":"Zou Q, Lei X, Xu A, Li Z, He Q, Huang X, et al. Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer. Front Immunol. 2022;13:724139.","journal-title":"Front Immunol"},{"issue":"5","key":"4468_CR11","first-page":"3581","volume":"25","author":"PK Baier","year":"2005","unstructured":"Baier PK, Eggstein S, Wolff-Vorbeck G, Baumgartner U, Hopt UT. Chemokines in human colorectal carcinoma. Anticancer Res. 2005;25(5):3581\u20134.","journal-title":"Anticancer Res"},{"key":"4468_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.955599","volume":"9","author":"IM Talaat","year":"2022","unstructured":"Talaat IM, Elemam NM, Zaher S, Saber-Ayad M. Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment. Front Med (Lausanne). 2022;9:955599.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"4468_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/cei.13415","volume":"200","author":"MA ElTanbouly","year":"2020","unstructured":"ElTanbouly MA, Schaafsma E, Noelle RJ, Lines JL. VISTA: Coming of age as a multi-lineage immune checkpoint. Clin Exp Immunol. 2020;200(2):120\u201330.","journal-title":"Clin Exp Immunol"},{"key":"4468_CR14","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3389\/fimmu.2019.01638","volume":"10","author":"R Hid Cadena","year":"2019","unstructured":"Hid Cadena R, Reitsema RD, Huitema MG, van Sleen Y, van der Geest KSM, Heeringa P, et al. Decreased expression of negative immune checkpoint VISTA by CD4+ T cells facilitates T helper 1, T helper 17, and T follicular helper lineage differentiation in GCA. Front Immunol. 2019;10:1638.","journal-title":"Front Immunol"},{"issue":"1","key":"4468_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s13046-019-1372-z","volume":"38","author":"A Zaravinos","year":"2019","unstructured":"Zaravinos A, Roufas C, Nagara M, de Lucas MB, Oblovatskaya M, Efstathiades C, et al. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer. J Exp Clin Cancer Res. 2019;38(1):364.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"4468_CR16","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s00262-021-02886-8","volume":"70","author":"R Liang","year":"2021","unstructured":"Liang R, Zhu X, Lan T, Ding D, Zheng Z, Chen T, et al. TIGIT promotes CD8(+)T cells exhaustion and predicts poor prognosis of colorectal cancer. Cancer Immunol Immunother. 2021;70(10):2781\u201393.","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"4468_CR17","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/1078-0432.CCR-15-1849","volume":"22","author":"HM Zarour","year":"2016","unstructured":"Zarour HM. Reversing T-cell dysfunction and exhaustion in cancer. Clin Cancer Res. 2016;22(8):1856\u201364.","journal-title":"Clin Cancer Res"},{"key":"4468_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102976","volume":"134","author":"X Wei","year":"2023","unstructured":"Wei X, Niu X. T follicular helper cells in autoimmune diseases. J Autoimmun. 2023;134:102976.","journal-title":"J Autoimmun"},{"issue":"6","key":"4468_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.humimm.2018.03.003","volume":"79","author":"E Jifu","year":"2018","unstructured":"Jifu E, Yan F, Kang Z, Zhu L, Xing J, Yu E. CD8(+)CXCR5(+) T cells in tumor-draining lymph nodes are highly activated and predict better prognosis in colorectal cancer. Hum Immunol. 2018;79(6):446\u201352.","journal-title":"Hum Immunol"},{"key":"4468_CR20","doi-asserted-by":"publisher","first-page":"1034764","DOI":"10.3389\/fmed.2022.1034764","volume":"9","author":"CN Turner","year":"2022","unstructured":"Turner CN, Mullins GN, Hoyer KK. CXCR5(+)CD8 T cells: Potential immunotherapy targets or drivers of immune-mediated adverse events? Front Med (Lausanne). 2022;9:1034764.","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"4468_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00262-025-04027-x","volume":"74","author":"Z Chen","year":"2025","unstructured":"Chen Z, Hu B, Cai K, Gao H, Xian Z, Zhang S, et al. Dynamics of tertiary lymphoid structures and immune cross talk in early versus advanced colorectal cancer: potential implications for immunotherapy. Cancer Immunol Immunother. 2025;74(6):185.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"4468_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12885-023-10667-y","volume":"23","author":"S Deng","year":"2023","unstructured":"Deng S, Zhu Q, Chen H, Xiao T, Zhu Y, Gao J, et al. Screening of prognosis-related Immune cells and prognostic predictors in colorectal cancer patients. BMC Cancer. 2023;23(1):195.","journal-title":"BMC Cancer"},{"issue":"25","key":"4468_CR23","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui C, Wang J, Fagerberg E, Chen PM, Connolly KA, Damo M, et al. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell. 2021;184(25):6101-18.e13.","journal-title":"Cell"},{"issue":"5","key":"4468_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1141857","volume":"5","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Luo Y, Qin SL, Mu YF, Qi Y, Yu MH, et al. The clinical impact of ICOS signal in colorectal cancer patients. Oncoimmunology. 2016;5(5):e1141857.","journal-title":"Oncoimmunology"},{"key":"4468_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/17588359251330514","volume":"17","author":"M Nikanjam","year":"2025","unstructured":"Nikanjam M, Kato S, Nishizaki D, Barkauskas DA, Pabla S, Nesline MK, et al. ICOS and ICOS ligand: expression patterns and outcomes in oncology patients. Ther Adv Med Oncol. 2025;17:17588359251330514.","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"4468_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/2159-8290.CD-14-1397","volume":"5","author":"Y Xiao","year":"2015","unstructured":"Xiao Y, Freeman GJ. The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy. Cancer Discov. 2015;5(1):16\u20138.","journal-title":"Cancer Discov"},{"issue":"1","key":"4468_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s43046-025-00287-x","volume":"37","author":"A Gamal El Dein Badary","year":"2025","unstructured":"Gamal El Dein Badary A, Bakry R, Rezk K, AF Amine M, M Zahran A. Expression of VISTA on T cells in patients with cancer colon. J Egypt Natl Canc Inst. 2025;37(1):41.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"10","key":"4468_CR28","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00262-020-02593-w","volume":"69","author":"R Saleh","year":"2020","unstructured":"Saleh R, Taha RZ, Toor SM, Sasidharan Nair V, Murshed K, Khawar M, et al. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer. Cancer Immunol Immunother. 2020;69(10):1989\u201399.","journal-title":"Cancer Immunol Immunother"},{"key":"4468_CR29","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.3389\/fimmu.2018.02821","volume":"9","author":"XM Zhou","year":"2018","unstructured":"Zhou XM, Li WQ, Wu YH, Han L, Cao XG, Yang XM, et al. Intrinsic expression of immune checkpoint molecule TIGIT could help tumor growth in vivo by suppressing the function of NK and CD8(+) T Cells. Front Immunol. 2018;9:2821.","journal-title":"Front Immunol"},{"key":"4468_CR30","doi-asserted-by":"crossref","unstructured":"Khademolhosseini A, Zamir MR, Moazzeni A, Mansourabadi Z, Safari E. VISTA: bridging gaps in cancer immunotherapy. Discov Oncol. 2026","DOI":"10.1007\/s12672-026-04407-4"},{"issue":"6","key":"4468_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, Vera-Badillo FE, Aneja P, Oca\u00f1a A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.","journal-title":"J Natl Cancer Inst"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04468-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04468-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04468-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:32:00Z","timestamp":1783535520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04468-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":31,"alternative-id":["4468"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04468-5","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of the Faculty of Medicine, Assiut University (IRB 04\u20132024-300483). The research was conducted in accordance with ethical principles of research involving human subjects as stated in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants prior to enrollment in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}